Payman Zamani, MD
Enriched profileAssociate Professor of Medicine (Cardiovascular Medicine) · University of Pennsylvania
Payman Zamani is Associate Professor of Medicine (Cardiovascular Medicine) at University of Pennsylvania. OpenAlex indexes 139 publications with 2,639 citations (h-index 26); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Payman Zamani is Associate Professor of Medicine (Cardiovascular Medicine) at University of Pennsylvania, Perelman School of Medicine / Hospital of the University of Pennsylvania. The public record shows 139 publications with 2,639 citations (h-index 26), centered on Heart Failure. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 3 companies, 3 NIH-funded awards (2016–2025).
- Most recent indexed publication: 2026 · Hypertension (Dallas, Tex.
- Top research focus: Heart Failure
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 14 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial
Sponsor: University of Pennsylvania
- Matching Perfusion and Metabolic Activity in HFpEF
Sponsor: University of Pennsylvania
- Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)
Sponsor: University of Pennsylvania
Industry payments
Updated 27 Aug 2026
3 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Kestra Medical Technology Services, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20231 payment
- PFIZER INC.Program year20211 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.9%Statin21.1%Rosuvastatin Calcium54%Atorvastatin Calcium46%Part D<11 patientsBeta blocker16.9%Carvedilol100%Part D<11 patientsMetabolism & gastrointestinal
27.1%SGLT2 inhibitor27.1%Farxiga76%Jardiance24%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
3 NIH research awards on record, funded 2016–2025 per NIH RePORTER. The latest:
- Targeting Skeletal Muscle Perfusion and Oxidative Capacity in HFpEF
University of Pennsylvania
FY2025$780,074R01HL155599 - Multidrug Metabolic Approach to Improve Exercise and Skeletal Muscle Oxidative Capacity in HFpEF
University of Pennsylvania
FY2025$692,625R01HL157264 - Targeting Skeletal Muscle Perfusion and Oxidative Capacity in HFpEF
University of Pennsylvania
FY2024$770,206R01HL155599
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Calcium Channel Blockade Versus β-Blockade for Hypertension in Heart Failure With Preserved Ejection Fraction: A Randomized Crossover Trial.
Hypertension (Dallas, Tex.
Clinical Trial2026 - Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure.
Circulation. Heart failure
Article2026 - Musclin Counteracts Skeletal Muscle Dysfunction and Exercise Intolerance in Heart Failure With Preserved Ejection Fraction.
Circulation. Heart failure
Article2025 - Transferrin Saturation, Serum Iron, and Ferritin in Heart Failure: Prognostic Significance and Proteomic Associations.
Circulation. Heart failure
Article2025 - Prognostic Significance and Biologic Associations of Senescence-Associated Secretory Phenotype Biomarkers in Heart Failure.
Journal of the American Heart Association
Article2024
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
hfsa.digitellinc.com/b/sp/payman-zamani-434
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.digitellinc.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗
- Board Certified
Advanced Heart Failure & Transplant Cardiology (ABIM)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
Editorial & leadership roles
journal and society appointments- Faculty Member
Institute for Diabetes, Obesity and Metabolism / Penn Diabetes Research Center, University of Pennsylvania
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.upenn.edu ↗ - Chair
Early Career/Trainee Committee, Heart Failure Society of America (HFSA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.digitellinc.com ↗ - Member
Programming Committee, HFSA Annual Scientific Meeting
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.digitellinc.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pennmedicine.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hfsa.digitellinc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Harold Feldman, MD
University of Pennsylvania
Howard Herrmann, MD
University of Pennsylvania
Robert Vonderheide, MD
University of Pennsylvania